Invasive disease due to group A β-hemolytic streptococci: Continued occurrence in children in North Carolina

Southern Medical Journal

Volumn 91, Issue 4, 1998, Pages 333-337

  Givner, Laurence B ^a,b  

^a Department of Pediatrics Wake Forest University Brenner Children's Hospital ^*

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

BACTERIUM ISOLATION; CHICKENPOX; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MALE; NEWBORN; PATHOGENESIS; REVIEW; SEROTYPING; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

EID: 0031923826     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199804000-00003     Document Type: Review

References (25)

1. Givner LB, Abramson JS, Wasilauskas B: Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991; 118:341-346
2. Wheeler MC, Roe MH, Kaplan EL, et al: Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. JAMA 1991; 266:533-537
3. Doctor A, Harper MB, Fleisher GR: Group A β-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 1995; 96:428-433
4. Peterson CL, Mascola L, Chao SM, et al: Children hospitalized for varicella: a prevaccine review. J Pediatr 1996; 129:529-536
5. Davies HD, McGeer A, Schwartz B, et al: Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335:547-554
6. Committee on Infectious Diseases: Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995; 95:791-796
7. Brogan TV, Nizet V, Waldhausen JHT, et al: Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14:588-594
8. Peterson CL, Vugia DJ, Meyers HB, et al: Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J 1996; 15:151-156
9. The Working Group on Severe Streptococcal Infections: Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269:390-391
10. Lohr JA, Thiede BA, Kaplan EL, et al: Characteristics of infected patients and isolates from an outbreak of invasive group A beta hemolytic streptococcal disease in North Carolina (Abstract). Pediatr Res 1995; 37:182A
11. Chelsom J, Halstensen A, Haga T, et al: Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344:1111-1115
12. Wilson GJ, Talkington DF, Gruber W, et al: Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis 1995; 20:1333-1338
13. Chow JW, Muder RR: Group A streptococcal meningitis. Clin Infect Dis 1992; 14:418-421
14. Gertner M, Rodriguez L, Barnett SH, et al: Group A beta-hemolytic Streptococcus and Waterhouse-Friderichsen syndrome. Pediatr Infect Dis J 1992; 11:595-596
15. Stevens DL: Invasive group A Streptococcus infections. Clin Infect Dis 1992; 14:2-13
16. Schwartz B, Facklam RR, Breiman RF: Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-1171
17. Johnson DR, Stevens DL, Kaplan EL: Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374-382
18. Rathore MH, Barton LL, Kaplan EL: Suppurative group A β-hemolytic streptococcal infections in children. Pediatrics 1992; 89:743-746
19. Belani K, Schlievert PM, Kaplan EL, et al: Association of exotoxin-producing group A streptococci and severe disease in children. Pediatr Infect Dis J 1991; 10:351-354
20. Cimolai N, Trombley C, Adderley RJ, et al: Invasive Streptococcus pyogenes infections in children. Can J Public Health 1992; 83:230-233
21. Vugia DJ, Peterson CL, Meyers HB, et al: Invasive group A streptococcal infections in children with varicella in southern California. Pediatr Infect Dis J 1996; 15:146-150
22. Talkington DF, Schwartz B, Black CM, et al: Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61:3369-3374
23. Holm SE, Norrby A, Bergholm A-M, et al: Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31-37
24. Stevens DL: Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1:69-78
25. Wessels MR, Moses AE, Goldberg JB, et al: Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci 1991; 88:8317-8321